HTA Database - Search Results

Sort by Relevance

Search Results [15895 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2019	Health Quality Ontario (HQO)	Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment
2019	Ontario Health	Osseointegrated Prosthetic Implants for People With Lower-Limb Amputation: A Health Technology Assessment
2019	Health Sciences Institute in Aragon (IACS)	Efficacy, effectiveness and safety of intraoperative radiotherapy in breast carcinoma
2019	Health Sciences Institute in Aragon (IACS)	Detection of diabetes' complications. Diabetic retinopathy. Economic evaluation of ultra-wide field scanning laser
2019	Ontario Health	Flash Glucose Monitoring System for People with Type 1 or Type 2 Diabetes: A Health Technology Assessment
2019	Ontario Health	Minimally invasive glaucoma surgery: a budget impact analysis and evaluation of patients’ experiences, preferences, and values
2019	Belgian Health Care Knowledge Centre (KCE)	Polyvalent immunoglobulins – Part 1: A rapid review
2019	Basque Office for Health Technology Assessment (OSTEBA)	[Closed vs open systems for the preparation and administration of cytostatic and other hazardous drugs (NIOSH Group 1): analysis of the scientific evidence, costs and organisational requirements]
2019	Basque Office for Health Technology Assessment (OSTEBA)	[Indications, utility and use of ultrasound in primary care]
2019	Basque Office for Health Technology Assessment (OSTEBA)	[Controlled and uncontrolled donation after circulatory death with regional normothermic or hypothermic perfusion based on extracorporeal membrane oxygenation for kidney and liver transplants]
2019	Basque Office for Health Technology Assessment (OSTEBA)	[Methodological project: Synthesis of information in support of multicriteria decision analysis (MCDA) for decision making]
2019	Adelaide Health Technology Assessment (AHTA)	Alpha Thalassaemia genetic testing
2019	Adelaide Health Technology Assessment (AHTA)	Serious adverse events associated with influenza vaccination
2019	Adelaide Health Technology Assessment (AHTA)	Faecal calprotectin testing in patients suspected of inflammatory bowel disease (IBD) presenting to primary care
2019	Adelaide Health Technology Assessment (AHTA)	Immunoglobulin for myasthenia gravis
2019	Adelaide Health Technology Assessment (AHTA)	Immunoglobulin for acquired hypogammaglobulinaemia secondary to haematological malignancies, or post-haemopoietic stem cell transplantation (HSCT)
2019	Health Technology Wales (HTW)	Procalcitonin point-of-care testing for initial assessment of suspected sepsis
2019	Health Technology Wales (HTW)	Fluorine- or gallium- prostate-specific membrane antigen (PSMA) positron emission tomography (PET) radiotracers in the investigation of recurrent prostate cancer
2019	Health Technology Wales (HTW)	Synovasure® Alpha Defensin Lateral Flow Test Kit for the assessment of periprosthetic joint infection
2019	Health Technology Wales (HTW)	Hand-held ultrasound devices for cardiac assessment and diagnosis of heart failure, in the community or primary care setting
2019	Health Technology Wales (HTW)	Continuous glucose monitoring systems for managing diabetes in pregnant women
2019	Health Technology Wales (HTW)	Pharmacogenetic testing to identify the risk of adverse reactions to anti-epileptic medications
2019	Health Technology Wales (HTW)	Occipital nerve stimulation for medically refractory chronic cluster headache
2019	Norwegian Institute of Public Health (NIPH)	Organ donation with the use of normothermic regional perfusion in patients who die after cardiac and respiratory arrest after withdrawal of life-sustaining treatment
2019	Norwegian Institute of Public Health (NIPH)	Disease modifying treatments for relapsing remitting multiple sclerosis. A health economic evaluation
2019	Norwegian Institute of Public Health (NIPH)	Disease-modifying treatments for relapsing remitting multiple sclerosis, including rituximab. A health technology assessment
2019	Norwegian Institute of Public Health (NIPH)	Prehospital CT for early diagnosis and treatment of suspected acute stroke or severe head injury
2019	Norwegian Institute of Public Health (NIPH)	Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer. Assessment of manufacturer’s submission
2019	Norwegian Institute of Public Health (NIPH)	Health technology assessment of Transcatether aortic valve implantation (TAVI) as treatment of patients with severe aortic stenosis and intermediate surgical risk – Part 2. Health economic evaluation
2019	Norwegian Institute of Public Health (NIPH)	Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke
2019	Norwegian Institute of Public Health (NIPH)	Hyperbaric oxygen therapy for osteonecrosis
2019	Penn Medicine Center for Evidence-based Practice (CEP)	The Effect of Patient Communication About Medical Errors on Malpractice Lawsuits
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Interventions to Reduce the Use of the High Risk Medications in Elderly Patients
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Guidelines for Supplementary Feedings of Newborn Infants
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: Alphanate - von Willebrand disease]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge, state of practice: Use of direct oral anticoagulants and warfarin in the context of atrial fibrillation and venous thromboembolism]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: anticoagulant therapy]
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Pulmonary Artery Catheters Catheter Dwell Time and Routine Replacement
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Dual Antiplatelet Therapy Following Revascularization for Peripheral Artery Disease
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Dosing of Botulinum Toxin for Neurologic Indications
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Management of Tunneled Dialysis Catheters in Patients with Bloodstream Infection
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: antidiabetics]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: autonomy in intellectually disabled young people aged 6 to 21 years]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: axicabtagene ciloleucel for the treatment of relapsed or refractory large B-cell lymphoma]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: Cutaquig, preparation of human immunoglobulins, notice of inclusion on the Liste des produits du système du sang du Québec]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: assessment of the relevance of newborn blood spot screening for biotinidase deficiency (BIOT)]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Localized and disseminated stages of Lyme disease: from diagnosis to treatment, report in support of the diagnosis and treatment decision support tools]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in June 2019: acute exacerbations of chronic obstructive pulmonary disease (AECOPD)]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in June 2019: urethral discharge]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: effects of assistance dogs and companion animals on persons with autism spectrum disorder or post-traumatic stress disorder]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: Esperoct (turoctocog alfa pegol) – Hemophilia A, notice of inclusion on the Liste des produits du système du sang du Québec]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: assessing the senior care and services continuum, prospects for measurement development]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated June 2019: palliative care - fever]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards, updated on May 4th 2020 : guide to preventing and treating chemotherapy or radiotherapy-induced nausea and vomiting in adults]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: HemlibraMC (emicizumab) - Hemophilia A, notice of inclusion on the Liste des produits du système du sang du Québec]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in July 2019: high blood pressure]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in October 2019: lipid-lowering pharmacologic agents]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: indications justifying the use of imaging for diagnosing patients with primary or secondary headache]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: managing the risk of suicide and self-harm among youths living in rehabilitation centres for young persons with adjustment problems]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: withdrawal management in adult addiction rehabilitation service centres]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: the placenta, utility of and indications for the transfer of samples to the anatomical pathology laboratory for analysis]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: post-tick bite antibiotic prophylaxis to prevent Lyme disease, report in support of the knowledge transfer tools, the Québec’s national medical protocol and the collective prescription template]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: mechanisms for accessing local services]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in August 2020: pharmacological treatment of nausea in a person receiving palliative care]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Organization of care and services for stroke to optimize access to endovascular treatment in Quebec]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in June 2019: unusual vaginal discharge]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: relevance of low-dose computed tomography lung cancer screening]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: portrait of the Quebec adult trauma care network: 2013 – 2016]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: setting safety and conditions for success of vaginal birth after cesarean]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: intensive outpatient services for youths with psychoactive substance use disorders]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: dose banding and dose rounding of antineoplastic agents]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: smoking cessation strategies]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: considerations relating to the adoption of the learning health-care system approach, the reflective approach, and audit and feedback in the context of managing chronic diseases and multimorbid states]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: respiratory multiplex NAAT (8 or more targets)]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: use of rifapentine in the treatment of latent tuberculosis infection]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: use of extracorporeal membrane oxygenation (ECMO) in adults in Quebec]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: use of linear accelerators with on-board magnetic resonance imaging (MRI) for real-time MRI-guided radiation therapy treatments]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: acute exacerbation of chronic obstructive pulmonary disease]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: The Argus II retinal implant]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: approach to managing access to cancer care: a review of the literature and practices]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: tisagenlecleucel for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: breast tomosynthesis and breast cancer screening]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: treatment of mitral regurgitation by a percutaneous device with clip (TMVRc)]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ external condylomas (anogenital warts)]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: best strategies for reducing the risk of severe toxicities caused by dihydropyrimidine dehydrogenase deficiency]
2019	National Committee for Technology Incorporation (CONITEC)	[Diagnostic tests for thrombophilia in pregnancy]
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Intravenous lidocaine for perioperative pain control
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Levalbuterol vs albuterol for hospitalized patients
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Triple-lumen peripherally-inserted central catheters
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Tip positioning of short-term central venous catheters
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Timing of valve replacement for patients with infective endocarditis and intracranial embolism
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Participation in athletics by persons with thoracic aortic disease
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Postoperative chlorhexidine bathing to reduce surgical site infections among patients undergoing cardiac surgery
2019	European Network for Health Technology Assessment (EUnetHTA)	Sotagliflozin indicated as an adjunct to insulin therapy to improve glycaemic control in adults with type 1 diabetes mellitus with a Body Mass Index (BMI) ≥ 27 kg/m2, who have failed to achieve adequate glycaemic control despite optimal insulin therapy
2019	European Network for Health Technology Assessment (EUnetHTA)	Ustekinumab for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response with, lost response to or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies
2019	European Network for Health Technology Assessment (EUnetHTA)	Stool DNA testing for early detection of colorectal cancer
2019	European Network for Health Technology Assessment (EUnetHTA)	C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections (RTIs)
2019	European Network for Health Technology Assessment (EUnetHTA)	Robot-assisted surgery in thoracic and visceral indications
2019	European Network for Health Technology Assessment (EUnetHTA)	Irreversible electroporation for the treatment of liver and pancreatic cancer